This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sheahan, K. Articles by Murnane, M. J. Search for Related Content PubMed PubMed Citation Articles by Sheahan, K. Articles by Murnane, M. J.

Cysteine Protease Activities and Tumor Development in Human Colorectal Carcinoma¹

Mallory Institute of Pathology [K. S., M. J. M.], and Departments of Pathology [K. S., S. S., M. J. M.] and Biochemistry [M. J. M.], Boston University School of Medicine, Boston, Massachusetts 02118

Many studies of malignant cells or tissues in culture have implicated cysteine proteases in the progression of malignancy. We have extended these observations by measuring quantitative and qualitative changes in the expression of cathepsin B-like and L-like cysteine proteases during the growth and development of human colorectal carcinomas. Data derived from matched pairs of normal colorectal mucosa and carcinoma tissue from 27 patients demonstrated that both cathepsin B-like and cathepsin L-like specific activities were significantly elevated (P < 0.005) in the carcinoma tissue, while levels of endogenous cysteine protease inhibitor remained constant. Correlation of cathepsin enzyme activities with different stages of colorectal cancer demonstrated significantly higher cysteine protease activities in individuals with Dukes' A tumors (tumors confined to the bowel wall) than in patients with more advanced tumors (Dukes' B, C, or D tumors) (P < 0.01-0.05). The relative proportion of activities contained in tumor epithelial and stromal elements remains to be elucidated. These results suggest an important role for cysteine proteases in the early progression of human colorectal carcinoma.

¹ This work was supported in part by American Cancer Society Grants PDT-349 and IN-97.

² To whom requests for reprints should be addressed, at Department of Pathology, L804, Boston University School of Medicine, 80 E. Concord St., Boston, MA 02118.

Received 11/29/88. Revised 3/27/89. Accepted 4/17/89.

This article has been cited by other articles:

				M.-J. Lee, G.-R. Yu, S.-H. Park, B.-H. Cho, J.-S. Ahn, H.-J. Park, E.-Y. Song, and D.-G. Kim Identification of Cystatin B as a Potential Serum Marker in Hepatocellular Carcinoma Clin. Cancer Res., February 15, 2008; 14(4): 1080 - 1089. [Abstract] [Full Text] [PDF]

				F. Boudreau, C. R. Lussier, S. Mongrain, M. Darsigny, J. L. Drouin, G. Doyon, E. R. Suh, J.-F. Beaulieu, N. Rivard, and N. Perreault Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia FASEB J, December 1, 2007; 21(14): 3853 - 3865. [Abstract] [Full Text] [PDF]

				C. S. Gondi, S. S. Lakka, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, C. H. Tung, R. Weissleder, and J. S. Rao Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas Cancer Res., June 15, 2004; 64(12): 4069 - 4077. [Abstract] [Full Text] [PDF]

				P. R. Collins, C. M. Stack, S. M. O'Neill, S. Doyle, T. Ryan, G. P. Brennan, A. Mousley, M. Stewart, A. G. Maule, J. P. Dalton, et al. Cathepsin L1, the Major Protease Involved in Liver Fluke (Fasciola hepatica) Virulence: PROPEPTIDE CLEAVAGE SITES AND AUTOACTIVATION OF THE ZYMOGEN SECRETED FROM GASTRODERMAL CELLS J. Biol. Chem., April 23, 2004; 279(17): 17038 - 17046. [Abstract] [Full Text] [PDF]

				B. A. Smith, W. J. Kennedy, P. Harnden, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate Identification of Genes Involved in Human Urothelial Cell-Matrix Interactions: Implications for the Progression Pathways of Malignant Urothelium Cancer Res., February 1, 2001; 61(4): 1678 - 1685. [Abstract] [Full Text]

				L. G. M. Hazen, F. E. Bleeker, B. Lauritzen, S. Bahns, J. Song, A. Jonker, B. E. M. Van Driel, H. Lyon, U. Hansen, A. Köhler, et al. Comparative Localization of Cathepsin B Protein and Activity in Colorectal Cancer J. Histochem. Cytochem., October 1, 2000; 48(10): 1421 - 1430. [Abstract] [Full Text]

				P. C. Almeida, I. L. Nantes, C. C. A. Rizzi, W. A. S. Judice, J. R. Chagas, L. Juliano, H. B. Nader, and I. L. S. Tersariol Cysteine Proteinase Activity Regulation. A POSSIBLE ROLE OF HEPARIN AND HEPARIN-LIKE GLYCOSAMINOGLYCANS J. Biol. Chem., October 22, 1999; 274(43): 30433 - 30438. [Abstract] [Full Text] [PDF]

				R. Menard, E. Carmona, S. Takebe, E. Dufour, C. Plouffe, P. Mason, and J. S. Mort Autocatalytic Processing of Recombinant Human Procathepsin L. CONTRIBUTION OF BOTH INTERMOLECULAR AND UNIMOLECULAR EVENTS IN THE PROCESSING OF PROCATHEPSIN L IN VITRO J. Biol. Chem., February 20, 1998; 273(8): 4478 - 4484. [Abstract] [Full Text] [PDF]

				C. A. Iacobuzio-Donahue, S. Shuja, J. Cai, P. Peng, and M. J. Murnane Elevations in Cathepsin B Protein Content and Enzyme Activity Occur Independently of Glycosylation during Colorectal Tumor Progression J. Biol. Chem., November 14, 1997; 272(46): 29190 - 29199. [Abstract] [Full Text] [PDF]

				D. W. Visscher, B. Sloane, W. Sakr, M. Sameni, D. Weaver, D. Bouwman, and J. D. Crissman Clinicopathologic Significance of Cathepsin B and Urokinase-type Plasminogen Activator Immunostaining in Colorectal Adenocarcinoma International Journal of Surgical Pathology, April 1, 1994; 1(4): 227 - 234. [Abstract] [PDF]